SearchCME LoginCE Login Show Cart
NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
CME Course Description
Login to view
Course Activities.

CME Live Virtual Conferences

Go Back

: Emerging Challenges in Primary Care 2018 St. Louis, MO
Activity/Course #:
: 05.12.18PC

: Free
Release/Start Date:
: May 12 2018
Expiration Date:
: May 12 2018
: Primary Care Medicine
Target Audience:
: Primary Care Providers
: Live EC Primary Care
Estimated Time To Complete CME Activity:
: 7.0 hours
: 7.0 AMA PRA Category I Credit(s)
7.0 AANP Contact hour(s) which includes 2.50 pharmacology hour(s)
Hardware/Software Requirements:
Saturday, May 12, 2018
Hyatt Regency St. Louis at the Arch
315 Chestnut Street
St. Louis, MO 63102
(314) 655-1234

Registration Fee
There is no registration fee for this activity.

Special Accommodations
NACE fully complies with the legal requirements of the Americans with Disabilities Act. Any activity registrant who feels s/he may need accommodations based on the impact of a disability should contact NACE to discuss your specific need.

Event Parking
Self-Parking is available at the Mansion House Garage, located directly behind the hotel at 330 N 4th St for $16.00 per day. This option is cash only.

Program Summary
Primary care providers face complex challenges everyday in their busy practices. With rapid changes in medicine, staying informed about new developments can be equally challenging. Our goal in this CME activity is to help you hone your skills in the diagnosis and management of patients with varied conditions you are likely encountering in your practice.

We have recruited a faculty of well-known thought leaders and experienced teachers who, as clinicians themselves, understand the challenges you face every day as a primary care provider. Our faculty will be at your disposal to provide evidence-based science, current treatment guidelines, discuss challenging cases, and provide answers for you that can ultimately lead to better health care for your patients. The presentations will include several interactive cases and discussion sessions to keep you actively learning.

Please join us and become an active participant in this one-day learning community of your peers.

Learning Objectives

  1. Recognize the pathogenesis of type 2 diabetes (T2DM) as a progressive, multi-defect disorder; Discuss the strengths and limitations of current guidelines for diabetes manager; Successfully use strategies for adherence to multiple medications to improve outcomes in diabetes; Examine data on current combination strategies to choose therapies that most effectively address a patient’s underlying pathophysiologic needs
  2. Discuss clinician and patient barriers to initiation and intensification of insulin therapy; Recognize the prevalence and clinical impact of hypoglycemia in special populations at risk; Discuss the pharmacology and clinical differences between existing and new long-acting and concentrated insulins; Discuss how to incorporate new basal and concentrated insulins into clinical practice while minimizing the risk of adverse events
  3. Review the risk factors and classification of pulmonary hypertension (PH); Discuss the appropriate diagnostic strategy for pulmonary arterial hypertension (PAH), including the roles of echocardiography, ventilation/perfusion (V/Q) scanning, and right heart catheterization (RHC); Review current and emerging treatments for patients with PAH; Describe how to monitor patients with PAH for disease progression
  4. Describe the newer concepts in the pathophysiology of asthma and type 2 inflammation, and the implications of biologic therapies in the era of precision medicine; Determine the utility of simple biomarkers to identify patients who are candidates for targeted biologic therapies and appropriate referral; Discuss the impact of comorbid conditions on asthma control and the evidence-based approach to their treatment; Discuss the paradigms of multidisciplinary care in asthma, with an emphasis on patient and provider education, to improve adherence to inhalers and emerging biologic therapies in asthma
  5. Recognize the difference between normal sadness and a Major Depressive Disorder; Develop a knowledge of the key criteria that differentiate Unipolar Depression from Bipolar Disorder; Provide information and tools for successful screening and recognition of patients with BD; Gain a better understanding of treatments approved for Unipolar versus Bipolar Depression
  6. Gain a better understanding of the prevalence and impact of sleep related problems; Understand the interaction between sleep related disorders and other health conditions: Learn the role for insomnia treatments approved for sleep initiation verses sleep maintenance; Gain a better understanding for practical tips on how to improve sleep hygiene


  Continental Breakfast and Registration
8:00-8:10   Welcome Remarks
Gregg Sherman, MD

The Progression of Type 2 Diabetes: A Rational Approach for Long Term Disease Management
Leann Olansky, MD, FACP, FACE

9:20-10:30   Safely Achieving Goals in Type 2 Diabetes (T2DM):The Role of Concentrated and Long-Acting Insulins
Leann Olansky, MD, FACP, FACE
10:30-10:50   Break
  The Role of Type 2 Inflammation in Severe Persistent Asthma: Integrating Biologic Therapy to Optimize Outcomes
Diego J. Maselli, MD, FCCP

Lunch will be provided


Evolving Strategies of Care in Pulmonary Arterial Hypertension: Integrating the Data into Practice
Alexander Duarte, MD

2:10-2:30   Break
2:30-3:40   Sad, Depressed or Bipolar?
Greg Mattingly, MD

Sleep is Not Overrated: Management Strategies in The Primary Care Setting
Greg Mattingly, MD

 Closing Remarks
Gregg Sherman, MD
*Agenda subject to change.
Alexander Duarte, MD
Professor, Division of Pulmonary Critical Care & Sleep Medicine
Department of Internal Medicine
University of Texas Medical Branch
Galveston, TX

Diego J. Maselli, MD FCCP
Assistant Professor of Medicine
Division of Pulmonary Diseases & Critical Care
University of Texas Health Science Center at San Antonio
Director, Respiratory Care, University Health System
Director, Severe Asthma Program, University Health System
San Antonio, TX

Greg Mattingly, MD      
Associate Clinical Professor
Department of Psychiatry
Washington University School of Medicine
St. Louis, MO

Leann Olansky, MD, FACP, FACE
Department of Endocrinology, Diabetes and Metabolism
Endocrinology & Metabolism Institute
Cleveland Clinic
Cleveland, OH

Planning Committee
Gregg Sherman, MD
Chief Medical Officer/Course Director
National Association for Continuing Education
Plantation, FL

Sheila Lucas, CWEP
Activity Director
National Association for Continuing Education
Plantation, FL

Sandy Bihlmeyer, M.Ed.
National Association for Continuing Education

Plantation, FL

Michelle Frisch, MPH, CHCP
National Association for Continuing Education
Plantation, FL

Harvey C. Parker, Ph.D., CHCP
National Association for Continuing Education
Plantation, FL

Sponsored and Certified By
National Association for Continuing Education
Accreditation Designation Statement
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The National Association for Continuing Education designates this live activity for a maximum of 7.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 7 Contact hour(s) of continuing education (which includes 2.5 pharmacology hours).
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the accredited providers to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the accredited providers are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships. Faculty disclosure will be provided in the activity materials.
Commercial Support
This activity is supported by an educational grant from Actelion Pharmaceuticals US, Inc., an educational grant from AstraZeneca Pharmaceuticals LP, an educational grant from Novo Nordisk Inc, and an educational grant from Lilly. For further information concerning Lilly grant funding visit